Skip to content Skip to sidebar Skip to footer

From idea to patent: protecting intellectual property in third-party medical device development

I

n the medical deviceindustry, a brilliant insight is often the starting point for revolutionizing a clinical procedure or improving operator safety. In this delicate transition from abstract concept to industrial-scale production, intellectual property protection becomes the pillar upon which a project's commercial success rests.

Developing medical devices - especially in the disposable sector - requires a complex balance between functional design, advanced material selection, and compliance with current regulations.

At Sidam , we help companies transform specific needs into market-ready devices, ensuring that every idea is secured and enhanced through rigorous certification and patenting processes. Being part of the Mirandola biomedical district means breathing innovation for over thirty years, but also understanding the true value of industrial secrecy.

ETHICS AND CONFIDENTIALITY: PROTECTING THE PROJECT FROM THE FIRST POINT OF CONTACT

Protecting an idea begins long before production. At Sidam, the first contact with a partner doesn't happen over a prototype, but over an NDA.

Signing a confidentiality agreement is a mandatory step for us, supported by an EN ISO 13485:2016certified quality management system. This standard guarantees not only product safety but also the rigorous control of all documentary processes and sensitive information exchanged with the partner.

Sidam also guarantees the compliance necessary for international distribution through its participation in the MDSAP (Medical Device Single Audit Program)This certification confirms that our business processes simultaneously meet the regulatory requirements of multiple global markets, ensuring data and project management that complies with the highest global standards of security and privacy.

This culture of secrecy is a value we have upheld since 1991. Managing development for third parties (as a CMO and CDMO) means becoming the custodians of our clients' industrial secrets. We treat external projects with the same rigor we apply to our proprietary products, aware that trust is the primary requirement for any successful collaboration.

TURNING CONCEPTS INTO ENGINEERED SOLUTIONS: HOW TO MAKE THE PROJECT SCALABLE

At Sidam, clients often approach us with a specific clinical need or a preliminary technical drawing. In these cases, our role evolves from manufacturer to development partner (CDMO)..

We don't just mold plastic components: we provide our R&D department and our three cleanrooms (ISO 7) to test, prototype, and make the idea industrially scalable.

This integrated approach allows us to solve complex challenges, such as adapting a radiology kit or creating connection systems for nuclear medicine, where millimeter precision is essential.

The efficiency of this process stems from our ability to act with speed. We can guarantee much faster response and execution times than large multinationals, thanks to a lean decision-making structure and direct contact between the client and our technical teams.

Every technical choice - from the use of high-biocompatibility polymers to packaging validation - is designed to maximize device performance while ensuring the client retains full ownership of the project, as provided for in our agreements.

THE NUTRIVENT™ EXPERIENCE: WHEN INNOVATION BECOMES AN INTERNATIONAL PATENT

Our ability to protect our partners' ideas is rooted in solid, direct experience. A concrete example is NutriVent™, a multifunctional nasogastric catheter fully designed and patented by Sidam. NutriVent™ represents the practical application of a method aimed at identifying unresolved clinical issues, translating them into technical solutions that integrate intellectual property protection from the very beginning.

Managing the entire process internally, from research to patent filing, has allowed us to refine a methodology that we now offer to our clients.

We know that a patent is a strategic asset to ensure technological exclusivity in the market: this is why, when collaborating on the development of a new third-party device, we act with the expertise of those who understand every pitfall of the bureaucratic and legal journey.

MDR CERTIFICATION: THE NECESSARY BRIDGE BETWEEN INVENTION AND THE MARKET

While a patent protects the intellectual property of an idea, regulatory compliance is what allows its actual commercialization. In a regulated sector like medical devices, these two dimensions must move in parallel: an innovation, no matter how brilliant and protected, only reaches its full value when it meets rigorous European safety requirements..

The implementation of EU Regulation 2017/745 (MDR) has significantly raised standards for the entire sector, making certification a complex challenge. While many companies struggle to adapt to these new parameters, Sidam provides its partners with constant support to obtain CE certifications, ensuring the development path faces no unforeseen delays.

In this way, we transform what many perceive as a bureaucratic obstacle into a fast track for product launch, protecting the initial investment and ensuring the long-term commercial viability of the device on an international scale.

AN ECOSYSTEM OF EXPERTISE AT THE SERVICE OF OUR PARTNERS

Sidam is a company that combines meticulous, almost artisanal attention to detail with high-tech production capacity. Working with us also provides direct access to the expertise of the Mirandola biomedical district: a world-class supply chain of skills that we share with our partners to transform every technical challenge into a successful medical device.

Our technical team is always ready to evaluate the engineering of new concepts or the optimization of existing devices, providing a framework that integrates legal protection and full alignment with regulatory requirements. Every proposal is analyzed through a preliminary technical consultation, managed according to the strictest industrial confidentiality protocols.

Developing a new medical device is a journey defined by technological challenges and regulatory rigor. Sidam's mission is to simplify this complexity, offering partners the peace of mind of secure, confidential, and technically flawless management. We transform your technical challenges into industrial assets ready for the global market.

en_US